Our serenity consortium

The SERENITY consortium comprises researchers and clinicians from eight European countries with specialties in different clinical fields, epidemiology and psychology.

Coordinators: Erik Klok & Professor Simon Noble

SERENITY aims to develop and evaluate a shared decision tool to support patients, their companions and healthcare professionals make evidence based and informed decisions regarding antithrombotic medicines near the end of life.
This will be achieved through a series of work packages including:
– a realist literature review
– a flash mob audit of current practice
– epidemiological database analysis of current practice in 3 countries
– qualitative interviews with patients, their companions, and clinical stakeholders
– a Delphi exercise top inform the content and design of the App
– development of a shared decision-making tool to be used as an App
– evaluation of the tool against standard practice

A targeted implementation and dissemination plan will be developed to enable the use of the SERENITY tool across Europe, as well as its incorporation in clinical guidelines and policies.

You can read the design of the study here:
Towards optimal use of antithrombotic therapy of people with cancer at the end of life: A research protocol for the development and implementation of the SERENITY shared decision support tool